At a NATCO lab in Hyderabad. Bayer is contesting the first ever compulsory license given to NATCO to produce Nexavar, an anti-cancer drug, at 3% the cost.
READ AT
http://www.thealternative.in/society/are-drug-patents-impeding-access-to-affordable-medicine/
DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO .....FOR BLOG HOME CLICK HERE
DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO .....FOR BLOG HOME CLICK HERE
Join me on twitter
Join me on google plus 
Googleplus
Googleplus
No comments:
Post a Comment